LND101001 / Lupin 
Welcome,         Profile    Billing    Logout  
 0 Diseases   1 Trial   1 Trial   1 News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
LND101001 / Lupin
2013-001851-11: A study to see how effective and safe two doses of the study drug, LND101001 are compared to a placebo when given to patients with Mild to Moderate Alzheimer’s Disease. A placebo is a dummy medication - looks like the study drug but has no active ingredient.

Ongoing
2
171
Europe
LND101001, Capsule, soft
Lupin Atlantis Holdings S.A., Lupin Limited, Lupin Limited, Lupin Atlantis Holdings S.A.,
Mild to Moderate Alzheimer’s Disease, Mild to Moderate Alzheimer’s Disease/Dementia, Diseases [C] - Nervous System Diseases [C10]
 
 

Download Options